8 results
Dermatologic Extraintestinal Manifestations in IBD - IBD Algorithm

Erythema Nodosum
Pyoderma Gangrenosum
Metastatic Crohn's Disease
Sweet Syndrome
EBA

Dr. Wade Billings @wabillin

#Dermatologic
- IBD Algorithm ... Disease Sweet Syndrome ... Manifestations #EIM #IBDAlgorithm ... #IBD #Algorithm ... gastroenterology #management
Acute Severe Ulcerative Colitis (ASUC) - IBD Algorithm

By Dr. Wade Billings @wabillin

#Acute #Severe #Ulcerative #Colitis #ASUC
Severe Ulcerative Colitis ... (ASUC) - IBD Algorithm ... #ASUC #IBD #Algorithm ... #IBDAlgorithm # ... gastroenterology #Management
SCAD: Segmental Colitis Associated with Diverticulosis - IBD Algorithm

SCAD: Inflammation of the inter-diverticular mucosa without involvement
Associated with ... Algorithm SCAD ... #IBD #Algorithm ... #IBDAlgorithm # ... management #gastroenterology
Irritable Bowel Syndrome (IBS) - Pathophysiology, Diagnosis and Management Algorithm
Risk factors: Previous acute enteric infection, Female
Diagnosis and Management ... Algorithm Risk ... , more common: Food ... Pathophysiology #Diagnosis #Management ... #Algorithm #gastroenterology
Irritable Bowel Syndrome (IBS) Management Algorithm
Step 1: Good communication, dietary and lifestyle advice
Abdominal Pain:
 • 1st
Irritable Bowel Syndrome ... (IBS) Management ... Algorithm Step ... 1: Good communication ... #IBS #Management
It is important to recognize Acute Decompensated Heart Failure (ADHF) as more than just simply a
starts with a good ... are excellent at evaluating ... acute coronary syndrome ... #differential #algorithm ... #management #cardiology
Immune Checkpoint Inhibitor-Mediated Colitis
Grade of Disease Severity:
 • G1: Increase < 4 BMs/day over baseline; mild
Inhibitor-Mediated Colitis ... indicated Diagnostic Evaluation ... CheckpointInhibitor #Colitis ... #diagnosis #management ... #algorithm #IBD
Myelodysplastic syndromes current treatment algorithm 2018.

From Blood Cancer Journal, Published 24 May 2018

Myelodysplastic syndromes (MDS) are
Myelodysplastic syndromes ... current treatment algorithm ... Myelodysplastic syndromes ... risk of clonal evolution ... reduce disease-associated